Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers
Heart failure (HF) is a common condition and one of the main morbidity and mortality factors in elderly patients. The incidence of HF progressively increases with age, reaching >10% in those aged 70 years or over. In the elderly population, both the diagnosis and the management of HF prove challe...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/1/32 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587733863759872 |
|---|---|
| author | Paulina Nadziakiewicz Wioletta Szczurek-Wasilewicz Bożena Szyguła-Jurkiewicz |
| author_facet | Paulina Nadziakiewicz Wioletta Szczurek-Wasilewicz Bożena Szyguła-Jurkiewicz |
| author_sort | Paulina Nadziakiewicz |
| collection | DOAJ |
| description | Heart failure (HF) is a common condition and one of the main morbidity and mortality factors in elderly patients. The incidence of HF progressively increases with age, reaching >10% in those aged 70 years or over. In the elderly population, both the diagnosis and the management of HF prove challenging, often requiring specialized care and a multidisciplinary approach. In seniors, atypical presentation of HF is much more common than in younger patients; thus, a holistic assessment with biomarkers related to HF allows for early diagnosis and accurate risk stratification in this group of patients. This article reviews the clinical and diagnostic differences in elderly patients with HF, highlighting the presence of comorbidities, frailty, cognitive impairment, and polypharmacy, as well as discussing potential biomarkers that may have clinical application in this population. |
| format | Article |
| id | doaj-art-b4d07f3f5b4e433aa3f932bf205c2dcc |
| institution | Kabale University |
| issn | 1424-8247 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj-art-b4d07f3f5b4e433aa3f932bf205c2dcc2025-01-24T13:45:05ZengMDPI AGPharmaceuticals1424-82472024-12-011813210.3390/ph18010032Heart Failure in Elderly Patients: Medical Management, Therapies and BiomarkersPaulina Nadziakiewicz0Wioletta Szczurek-Wasilewicz1Bożena Szyguła-Jurkiewicz2Student’s Scientific Society, 3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandDepartment of Pharmacology, Faculty of Medicine, University of Opole, 45-052 Opole, Poland3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, PolandHeart failure (HF) is a common condition and one of the main morbidity and mortality factors in elderly patients. The incidence of HF progressively increases with age, reaching >10% in those aged 70 years or over. In the elderly population, both the diagnosis and the management of HF prove challenging, often requiring specialized care and a multidisciplinary approach. In seniors, atypical presentation of HF is much more common than in younger patients; thus, a holistic assessment with biomarkers related to HF allows for early diagnosis and accurate risk stratification in this group of patients. This article reviews the clinical and diagnostic differences in elderly patients with HF, highlighting the presence of comorbidities, frailty, cognitive impairment, and polypharmacy, as well as discussing potential biomarkers that may have clinical application in this population.https://www.mdpi.com/1424-8247/18/1/32heart failurebiomarkerselderly patientspharmacological treatmentcomorbidities |
| spellingShingle | Paulina Nadziakiewicz Wioletta Szczurek-Wasilewicz Bożena Szyguła-Jurkiewicz Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers Pharmaceuticals heart failure biomarkers elderly patients pharmacological treatment comorbidities |
| title | Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers |
| title_full | Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers |
| title_fullStr | Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers |
| title_full_unstemmed | Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers |
| title_short | Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers |
| title_sort | heart failure in elderly patients medical management therapies and biomarkers |
| topic | heart failure biomarkers elderly patients pharmacological treatment comorbidities |
| url | https://www.mdpi.com/1424-8247/18/1/32 |
| work_keys_str_mv | AT paulinanadziakiewicz heartfailureinelderlypatientsmedicalmanagementtherapiesandbiomarkers AT wiolettaszczurekwasilewicz heartfailureinelderlypatientsmedicalmanagementtherapiesandbiomarkers AT bozenaszygułajurkiewicz heartfailureinelderlypatientsmedicalmanagementtherapiesandbiomarkers |